S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

NCT00075764 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

695

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: anastrozole
DRUG: fulvestrant

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]